Stocksigma LogoStocksigma Logo

USFDA Completes Records Assessment at Dr. Reddy鈥檚 Mexico Facility with Two Observations

The USFDA concluded a records assessment under Section 704(a)(4) of the Federal Food, Drug, and Cosmetic Act for Dr

USFDA Completes Records Assessment at Dr. Reddy鈥檚 Mexico Facility with Two Observations

Dr Reddys Laboratories Ltd 路 Others (Uncategorized) 路 12 Sept 2026, 3:37 am

USFDA Completes Records Assessment at Dr. Reddy鈥檚 Mexico Facility with Two Observations The USFDA concluded a records assessment under Section 704(a)(4) of the Federal Food, Drug, and Cosmetic Act for Dr. Reddy鈥檚 Laboratories' API manufacturing facility in Jiutepec, Morelos, Mexico (Industrias Qu铆micas Falc贸n de M茅xico). Conducted between 17th Jul'26 and 8th Sep'26, the inspection resulted in the issuance of a Form FDA 2953 with two observations. The company stated it will respond to the observations within the stipulated timeline.

Original exchange filing (PDF)

More announcements from Dr Reddys Laboratories Ltd

All Dr Reddys Laboratories Ltd announcements